Symptomatic Knee Osteoarthritis Clinical Trial
Official title:
A Randomized, Two-arm, Placebo-controlled, Participant and Investigator-blinded Study Investigating the Efficacy, Safety and Tolerability of DFV890 in Patients With Symptomatic Knee Osteoarthritis
This is a double-blinded, two-arm, phase II study to assess efficacy, safety and tolerability of DFV890 in participants with symptomatic knee osteoarthritis. The study includes a screening period, a treatment period and a follow-up period. At most, the study duration is 21 weeks.
The purpose of the Phase 2a proof of concept study is to evaluate the safety and tolerability of DFV890 in participants with symptomatic knee OA, and to determine the efficacy of DFV890 in reducing knee pain as evidenced by change in KOOS (knee injury and osteoarthritis outcome score). ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01440972 -
Assessment of Efficacy of Low Intensity Resistance Training in Women at Risk for Symptomatic Knee Osteoarthritis
|
N/A | |
| Completed |
NCT04783792 -
The Effect of Phenolic Compounds in Osteoarthritis; a Nutritional Intervention
|
N/A | |
| Completed |
NCT03527693 -
Micro-fragmented Adipose Tissue Injection Associated With Arthroscopic Procedures in Patients With Knee Osteoarthritis
|
||
| Completed |
NCT01311206 -
Low Intensity Resistance Training With Partial Blood Flow Restriction for Quadriceps Strengthening
|
N/A |